English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation Journal article
Xie, Daping, Han, Congwei, Chen, Chonghao, Liao, Zhencheng, Campos de Souza, Senio, Niu, Yiming, Mano, João F., Dong, Lei, Wang, Chunming. A scaffold vaccine to promote tumor antigen cross-presentation via sustained toll-like receptor-2 (TLR2) activation[J]. Bioactive Materials, 2024, 37, 315-330.
Authors:  Xie, Daping;  Han, Congwei;  Chen, Chonghao;  Liao, Zhencheng;  Campos de Souza, Senio; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:18.0/18.2 | Submit date：2024/05/16
Scaffold Vaccine  Tlr2 Agonist  Polysaccharide  Reactive Oxygen Species  Cross-presentation  
Discovery and Development of Therapeutic TACE (ADAM17) Antibodies Conference paper
Kwok, H. F., Botkjaer, K., Tape, C., Huang, Y., McCafferty, J., Murphy, G.. Discovery and Development of Therapeutic TACE (ADAM17) Antibodies[C], 2015.
Authors:  Kwok, H. F.;  Botkjaer, K.;  Tape, C.;  Huang, Y.;  McCafferty, J.; et al.
Favorite |  | Submit date：2022/06/02
Cross-Reactive  Anti-TACE Antibody  Mouse Models